➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Dipyridamole - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for dipyridamole and what is the scope of freedom to operate?

Dipyridamole is the generic ingredient in three branded drugs marketed by Athenex Inc, Dr Reddys, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, West-ward Pharms Int, Boehringer Ingelheim, Ani Pharms Inc, Barr, Glenmark Generics, Impax Labs, Lannett Co Inc, Murty Pharms, Oxford Pharms, Purepac Pharm, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for dipyridamole. Eight suppliers are listed for this compound.

Drug Prices for dipyridamole

See drug prices for dipyridamole

Recent Clinical Trials for dipyridamole

Identify potential brand extensions & 505(b)(2) entrants

Temple UniversityPhase 2
Rutgers, The State University of New JerseyPhase 3
Yogendra KanthiPhase 2

See all dipyridamole clinical trials

Pharmacology for dipyridamole
Medical Subject Heading (MeSH) Categories for dipyridamole

US Patents and Regulatory Information for dipyridamole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040898-003 Apr 23, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs DIPYRIDAMOLE dipyridamole TABLET;ORAL 040782-001 Jul 18, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int DIPYRIDAMOLE dipyridamole INJECTABLE;INJECTION 074521-001 Oct 18, 1996 AP RX No No   Start Trial   Start Trial   Start Trial
Athenex Inc DIPYRIDAMOLE dipyridamole INJECTABLE;INJECTION 074939-001 Apr 13, 1998 AP RX No Yes   Start Trial   Start Trial   Start Trial
Ani Pharms Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 086944-001 Feb 25, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-002 Jan 28, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.